PRESS

IN THE NEWS

September 17, 2018

Interview – CEOCFO Magazine September 17, 2018 Issue

Q&A with Dr. Corey A. Carter, President and CEO of EpicentRx Inc. developing “smart” oncolytic virus therapies in combining immuno-oncology agents that activate the human immune system against cancer with minimal toxicity for patients